. Author manuscript; available in PMC: 2014 May 1.

Published in final edited form as: Eur Respir J. 2012 Aug 16;41(5):1023–1030. doi: 10.1183/09031936.00077012

Table 2.

Pulmonary Function Testing^#

		Resistant	Controls	Susceptible	p^ƒ
Pre 9/11 FEV₁		117(107–124)	102(92–112)	89(82–96)	<0.001

MME FEV₁		105(96–113)	92(82–99)	79(72–89)	<0.001

	FEV₁	113(109–118)	95(84–103)	72(67–75)	<0.001
	MCT Slope^¶	0.039(0.02–0.07)	0.048(0.03–0.12)	0.15(0.05–1.8)	<0.001
SPE	DLCO % Predicted⁺	119(108–135)	106(99–116)	95(84–107)	<0.001
	BD Response^§	4(2–8)	5(2–10)	15(7–28)	<0.001

Values Expressed as Median (Inter Quartile Range)

^¶

MCT Slope: Controls N=94; Resistant Cases N=57; Susceptible Cases N=32

⁺

DLCO % Predicted: Controls N=59; Resistant Cases N=24; Susceptible Cases N=44

^§

BD Response : Controls N=64; Resistant Cases N=26; Susceptible Cases=48

^ƒ

Significance assessed by one-way ANOVA Kruskal Wallis between Resistant, Susceptible Cases and Controls

Abbreviation Dictionary: MCT: Methacholine Challenge Test; BD: Bronchodilator; DLCO: Diffusion Capacity of the Lung for Carbon Monoxide; FEV₁, Forced Expiratory Capacity in 1 second